Status:
UNKNOWN
Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics
Lead Sponsor:
St. Vincent's East, Birmingham, Alabama
Collaborating Sponsors:
Master Supplements, Inc
Conditions:
Development of Clostridium Difficile Associated Diarrhea
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
We have designed this study to measure the effect of normal flora supplementation, using available probiotics, on the incidence of Clostridium difficile-associated diarrhea in a population of general...
Detailed Description
General medical-surgical patients in a community hospital who are receiving antibiotics, and who agree to participate, will be given one of two different probiotics, or placebo. Data will be gathered ...
Eligibility Criteria
Inclusion
- Any hospitalized patient who is age 19 or older and receiving antibiotics.
- \-
Exclusion
- Feeding tube in place
- Pregnancy
- Milk or soy allergy
- Sensitivity to lactose
- Immunocompromised defined as:
- Absolute neutrophil count (ANC) ≤ 500 cells/mm3
- HIV
- Cancer patient receiving chemotherapy or radiation therapy
- Immune deficiency
- Post organ transplant
- Participants will be withdrawn from the study if they develop any of the exclusion criteria during the hospitalization.
- \-
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01873872
Start Date
July 1 2013
End Date
March 1 2014
Last Update
March 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Vincent's East
Birmingham, Alabama, United States, 35235